Get the latest Science News and Discoveries
ECOG-ACRIN adds another trial to the ComboMATCH precision oncology study platform - EurekAlert
Another ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) treatment trial is open as part of the ComboMATCH precision medicine study platform. ComboMATCH-E5 is evaluating treatment for patients with <em>KRAS</em> G12C-mutated advanced solid tumors with two different targeted drugs given together.
None
Or read this on Eureka Alert